Humana trades near fair value, reflecting a mixed profit outlook and Medicare Advantage uncertainties. Click here to read an ...

Humana (HUM) stock has remained sideways for the year with the company lowering its full-year earnings outlook. While Humana ...

Humana (HUM) has been on a choppy path lately, with the stock slipping over the past 3 months even as profits grow. That gap between earnings momentum and price is what matters now. See our latest ...

Across the recent three months, 12 analysts have shared their insights on Humana (NYSE:HUM), expressing a variety of opinions spanning from bullish to bearish. In the table below, you'll find a ...

Shares of Humana Inc. (NYSE:HUM) dropped around 4% in pre-market trading on Tuesday after the healthcare insurer disclosed an ...

Louisville, Ky.-based Humana’s share price dropped 18.6 percent from its June 21 high of $190.07 amid rising doubts its proposed acquisition by Hartford, Conn.-based Aetna will falter, the Hartford ...

Humana (HUM) has quietly climbed about 11% over the past month, outpacing its performance over the past 3 months and 3 years. That move has investors rechecking what they are really paying for its ...

Humana's stock fell by 9 percent last week before rebounding, as the Aetna/Humana merger is facing scrutiny over the consolidation of two of the giants of the Medicare Advantage market. On Tuesday, ...

UnitedHealth Group Incorporated UNH and Humana Inc. HUM are two of the most prominent players in the U.S. health insurance space. Both operate in the managed healthcare space, offering health plans, ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $230.0 and $280.0 for Humana, spanning the last three months.

Humana posted a Q4 adjusted EPS loss of $(2.16), compared to $(0.11) last year, in line with expectations. Q4 revenue rose 13.5% YoY to $29.19B, exceeding the $28.84B consensus estimate. Get the ...